MedTrace Logo

Safety Study of Whole Body Hyperthermia for Advanced Cancer

NCT04467593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-08-05

No results posted yet for this study

Summary

Millions of patients die of cancer every year. There are several methods to treat cancer, including surgery, chemotherapy, radiotherapy and immunotherapy. Recently, hyperthermia therapy started playing a role in cancer therapy. It has shown effect in animal experiments and clinical practice. The sponsor has developed a novel device to use hyperthermia for advanced cancer. This study is to prove the safety in human patients of this device \& therapy and get the first data on efficacy.

Conditions

Interventions

DEVICE

Whole body hyperthermia

Whole body hyperthermia to treat stage IV cancer patients

DRUG

Standard of Care (SOC) chemotherapy according to the NCCN guidelines.

Whole body hyperthermia to treat stage IV pancreatic cancer patients combined with standard of care chemotherapy

Sponsors & Collaborators

  • ElmediX

    lead INDUSTRY

Principal Investigators

  • Marc Peeters, MD PhD · University Hospital, Antwerp

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-28
Primary Completion
2024-12-25
Completion
2024-12-25

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04467593 on ClinicalTrials.gov